Software & Developer Tools
Advaxis
United Statesadvaxis.com
Advaxis is a Software & Developer Tools startup based in the United States, most recent round Series C+, 1 tracked investor.
Acquiredseries-c-plus
series-c-plus
Stage
1
Investors
About Advaxis
Advaxis is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Software & Developer Tools. Brouky records 1 investor associated with the company.
Advaxis was an American biotechnology company focused on the discovery, development, and commercialization of immunotherapies based on a genetically engineered platform using Listeria monocytogenes (Lm). The company merged with Ayala Pharmaceuticals in January 2023.
Explore Advaxis's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.